Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 8/2016

01-08-2016

Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime

Auteurs: Haomiao Jia, Erica I. Lubetkin

Gepubliceerd in: Quality of Life Research | Uitgave 8/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To estimate quality-adjusted life years (QALY) loss due to each of the following nine chronic conditions—depression, diabetes mellitus, hypertension, heart disease, stroke, emphysema, asthma, arthritis, and cancer.

Methods

We ascertained respondents’ health-related quality of life scores and mortality status from the 2005 to 2008 National Health and Nutrition Examination Survey (NHANES) with mortality follow-up data through December 31, 2011. We included respondents aged 65 years and older (n = 2380). A hybrid estimator was used to calculate QALY from two parts: QALY during the follow-up period and QALY beyond the follow-up period. We calculated QALY by each of the nine chronic conditions.

Results

For persons aged 65 and older, QALY throughout the reminder of lifetime was 12.3 years. After adjusting for age- and sex-related differences, depression had an associated 8.2 years of QALY loss; diabetes, 5.6 years; hypertension, 2.5 years; heart disease, 5.4 years; stroke, 6.4 years; emphysema, 8.0 years; asthma, 4.8 years; arthritis, 0.3 years; and cancer, 2.5 years. Compared to persons without any chronic conditions, persons with one condition had an associated 4.7 years of QALY loss; persons with two conditions, 7.9 years; and persons with three or more conditions, 10.8 years.

Conclusions

This study presents a QALY estimator for respondents in the NHANES-Linked Mortality File and demonstrates the utility of this method to other follow-up data. Continued application of our method would enable the burden of disease to be compared for a range of health conditions and risk factors in the ongoing effort to improve population health.
vorige artikel Home but still engaged: participation in social activities among the homebound
volgende artikel Relationship of moderate alcohol intake and type of beverage with health behaviors and quality of life in elderly subjects
Literatuur
1.
Institute of Medicine. (2012). Living well with chronic illness: A call for public health action. Washington, DC: The National Academies Press.
2.
Roglic, G., & Unwin, N. (2010). Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Research and Clinical Practice, 87(1), 15–19.CrossRefPubMed
3.
Holmes, J., McGill, S., Kind, P., Bottomley, J., Gillam, S., & Murphy, M. (2000). Health-related quality of life in type 2 diabetes (TARDIS-2). Value in Health, 3(Suppl 1), 47–51.CrossRefPubMed
4.
Field, M. J., & Gold, M. R. (Eds.). (1998). Summarizing population health: Directions for the development and application of population metrics. Washington, DC: Institute of Medicine, National Academy Press.
5.
Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
6.
Brown, D. S., Jia, H., Zack, M. M., Thompson, W. W., Haddix, A. C., & Kaplan, R. M. (2013). Using health-related quality of life and quality-adjusted life expectancy for effective public health surveillance and prevention. Expert Review of Pharmacoeconomics and Outcomes Research, 13(4), 425–427.CrossRefPubMed
7.
Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23, 115–134.CrossRefPubMed
8.
Murray, C. J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2197–2223.CrossRefPubMed
9.
10.
Chiang, C. L. (1984). Statistical inference regarding life table functions. In C. L. Chiang (Ed.), The life table and its applications (pp. 153–167). Malabar, FL: Robert E. Krieger Publishers.
11.
National Research Council. (2010). Accounting for health and health care: Approaches to measuring the sources and costs of their improvement. Panel to Advance a research program on the Design of National Health Accounts, Committee on National Statistics, Division of Behavioral and Social Sciences and Education. Washington, DC: The National Academies Press.
12.
Jia, H., Zack, H. H., & Thompson, W. W. (2011). State quality-adjusted life expectancy for US adults from 1993 to 2008. Quality of Life Research, 20(6), 853–863.CrossRefPubMed
13.
Glasziou, P. P., Simes, R. J., & Gelber, R. D. (1990). Quality adjusted survival analysis. Statistics in Medicine, 9, 1259–1276.CrossRefPubMed
14.
Shen, L. Z., Pulkstenis, E., & Moseyni, M. (1999). Estimation of mean quality adjusted survival time. Statistics in Medicine, 18, 1541–1554.CrossRefPubMed
15.
Gong, Q., & Fang, L. (2012). Asymptotic properties of mean survival estimate based on the Kaplan–Meier curve with an extrapolated tail. Pharmaceutical Statistics, 11, 135–140.CrossRefPubMed
16.
Stewart, S. T., Cutler, D. M., & Rosen, A. B. (2013). US trends in quality-adjusted life expectancy from 1987 to 2008: Combining national surveys to more broadly track the health of the nation. American Journal of Public Health, 103(11), e78–e87.CrossRefPubMedPubMedCentral
17.
Jia, H., Zack, M. M., & Thompson, W. W. (2013). The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value in Health, 16(1), 140–147.CrossRefPubMed
18.
Jia, H., Zack, M. M., Thompson, W. W., & Dube, S. R. (2013). Quality-adjusted life expectancy (QALE) loss due to smoking in the United States. Quality of Life Research, 22(1), 27–35.CrossRefPubMed
19.
Lee, H. Y., Hwang, J. S., Jeng, J. S., & Wang, J. D. (2010). Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up. Stroke, 41(4), 739–744.CrossRefPubMed
20.
Oyunbileg, S., Wang, J. D., Sumberzul, N., Chang, Y. Y., & Erdenchimeg, E. (2011). Health impact of pneumoconiosis in Mongolia: Estimation of losses in life expectancy and quality adjusted life expectancy. American Journal of Indian Medicine, 54(4), 285–292.CrossRef
21.
Richardson, G., & Manca, A. (2004). Calculation of quality adjusted life years in the published literature: A review of methodology and transparency. Health Economics, 12, 1203–1210.CrossRef
22.
Ong, K. L., Wu, B. J., Cheung, B. M., Barter, P. J., & Rye, K. A. (2013). Arthritis: Its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Annals of Epidemiology, 23(2), 80–86.CrossRefPubMed
23.
Heron, M. (2015). Deaths: Leading causes for 2011. National Vital Statistics Reports, 64(7), 1–96.
24.
U.S. Burden of Disease Collaborators. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–608.CrossRef
25.
26.
27.
Centers for Disease Control and Prevention. (2000). Measuring healthy days: Population assessment of health-related quality of life. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Division of Adult and Community Health. http://​www.​cdc.​gov/​hrqol/​pdfs/​mhd.​pdf. Accessed 20 July 2015.
28.
Jia, H., & Lubetkin, E. I. (2008). Estimating EuroQol EQ-5D scores from population healthy days data. Medical Decision Making, 28(4), 491–499.CrossRefPubMed
29.
Jia, H., Zack, M. M., Moriarty, D. G., & Fryback, D. G. (2011). Predicting the EuroQol Group’s EQ-5D Index from CDC’s “Healthy Days” in a US sample. Medical Decision Making, 31(1), 174–185.CrossRefPubMed
30.
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173.CrossRefPubMed
31.
Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424.CrossRefPubMedPubMedCentral
32.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., & Murray, C. J. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study. PLoS Medicine, 10(11), e1001547.CrossRefPubMedPubMedCentral
33.
Jia, H., Zack, M. M., Thompson, W. W., Crosby, A. E., & Gottesman, I. I. (2015). Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide. Social Psychiatry and Psychiatric Epidemiology, 50(6), 939–949.CrossRefPubMedPubMedCentral
34.
35.
36.
Welch, H. G., & Black, W. C. (2010). Overdiagnosis in cancer. Journal of the National Cancer Institute, 102, 605–613.CrossRefPubMed
37.
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2163–2196.CrossRefPubMed
38.
Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., et al. (2007). Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. Journal of General Internal Medicine, 22(Suppl 3), 391–395.CrossRefPubMedPubMedCentral
39.
Seligman, F., & Nemeroff, C. B. (2015). The interface of depression and cardiovascular disease: Therapeutic implications. Annals of the New York Academy of Science, 1345(1), 25–35.CrossRef
Metagegevens
Titel
Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime
Auteurs
Haomiao Jia
Erica I. Lubetkin
Publicatiedatum
01-08-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1226-5

Andere artikelen Uitgave 8/2016

Quality of Life Research 8/2016 Naar de uitgave

OriginalPaper

Factors associated with depressive symptoms in young long-term breast cancer survivors

OriginalPaper

Impact of a community-based lifestyle intervention program on health-related quality of life

Review

The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review

OriginalPaper

Trajectories and associated factors of quality of life, global outcome, and post-concussion symptoms in the first year following mild traumatic brain injury

OriginalPaper

Fluctuating patterns in quality of life outcomes among patients with moderate and severe stages of chronic obstructive pulmonary disease

OriginalPaper

Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?